Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 21Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Glioblastoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Thyroid Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Neoplasms 1Liver Neoplasms 1Hematologic Neoplasms 1Glioma 1Gallbladder Neoplasms 1Esthesioneuroblastoma, Olfactory 1Endometrial Neoplasms 1Desmoid Tumors 1Craniopharyngioma 1Childhood Central Nervous System Choriocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Carboplatin 5Filgrastim 4Thiotepa 3Temozolomide 3Radiotherapy 3Cyclophosphamide 3sargramostim 2fludarabine 2aldesleukin 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Busulfan 2sodium thiosulfate 1pembrolizumab 1ixabepilone 1fludarabine phosphate 1etoposide phosphate 1erythromycin propionate-N-acetylcysteinate 1brodalumab 1Topotecan 1Thrombopoietin 1Tamoxifen 1Stem Cell Transplantation 1Sevoflurane 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Quality of Life 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Fluorouracil × CNS × Clear all
NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Leaf Vertical Inc.

Phase 1/2 Unknown
160 enrolled
CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡